Chiasma

+$0.13 (+3.37%) As of 5:53 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Chiasma and other ETFs, options, and stocks.

About CHMA

Chiasma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of oral forms of therapies that are available by injection. Its products include octreotide capsules.

CEO
Raj Kannan
Employees
85
Headquarters
Needham, Massachusetts
Founded
2001

CHMA Key Statistics

Market Cap
261.53M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
405.07K
High Today
$4.14
Low Today
$3.99
Open Price
$4.00
Volume
154.25K
52 Week High
$5.74
52 Week Low
$2.77

CHMA News

Simply Wall StJul 29

When Will Chiasma, Inc. Breakeven?

Chiasma, Inc. (NASDAQ:CHMA) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Chiasma, Inc., a c

CHMA Earnings

-$0.50
-$0.33
-$0.17
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure